N-acetylcystein(drug)
Drugp.O t.Siran 200mg x1 during one weak
Other names: siran
NCT Number: NCT00337038
Our aim is to examine the influence of blood pressure and glycemic control together with N-acetylcystein utilization on the endothelia function of hypertensive diabetic patient.The study population will include 50 diabetic patient with uncontrolled hypertention that will be recruited from the Hypertension Clinic of Soroka University Medical Center.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
p.O t.Siran 200mg x1 during one weak
Other names: siran
Time frame: half of year
Time frame: half of year
Soroka University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06543706
Body Weight, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06235762
COVID-19, Cardiovascular Diseases
São José do Rio Preto, São Paulo, Brazil
View Trial DetailsNCT01578837
Cardiovascular Diseases, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT01547156
Cardiovascular Diseases, Diabetes Mellitus
Sipoo, Finland
View Trial Details